DNA methylation arrays for new CCG studies period of performance 09/02/2020 - 09/01/2023 fully funded, non-severable, fixed price task order
Ended Awarded Last action
- Contract number
- 75N91020F00001
- Awardee
-
New York Genome Center, Inc. UEI WKPTJDWG2C68
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $274,036
Award facts
- Opportunity
-
- GCCTSB52020 Solicitation number
- Contract value 100% obligated
- $274,036.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10013, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$92,664 | |
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $113,400 | |
| Original award | $253,300 |
About this award
This is a $274,036 fixed-price task order awarded to the New York Genome Center, Inc. (Nygc) by the National Cancer Institute (NCI) under the NCI Genomic Characterization Centers master IDIQ contract. The purpose is to provide DNA methylation arrays to support new studies by the Cancer Genomics Program over a 3-year period of performance from September 2020 to September 2023. This task order is fully funded and non-severable. Nygc is a nonprofit academic research institution that provides genomic sequencing, analysis, and computational services to federal agencies through contracts and grants, often in collaboration with academic partners. The award does not have a set-aside designation, reflecting the specialized nature of Nygc's genomic services.
Quick answers
Who was awarded contract 75N91020F00001?
75N91020F00001 was awarded to New York Genome Center, Inc. by National Cancer Institute (National Institutes of Health) on September 2, 2020.
How much is contract 75N91020F00001 worth?
The government has obligated $274,036 on 75N91020F00001.
Is contract 75N91020F00001 an order under another contract?
Yes. 75N91020F00001 is a delivery order under 75N91019D00032, an indefinite delivery contract, on NCI Genomic Characterization Centers.
Was contract 75N91020F00001 competed?
The extent of competition for 75N91020F00001 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award